Intervention Review

Heparin versus placebo for acute coronary syndromes

  1. Kirk Magee1,*,
  2. Samuel G Campbell1,
  3. David Moher2,
  4. Brian H Rowe3

Editorial Group: Cochrane Heart Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 27 JAN 2008

DOI: 10.1002/14651858.CD003462.pub2

How to Cite

Magee K, Campbell SG, Moher D, Rowe BH. Heparin versus placebo for acute coronary syndromes. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD003462. DOI: 10.1002/14651858.CD003462.pub2.

Author Information

  1. 1

    Dalhousie University, Department of Emergency Medicine, Halifax, Nova Scotia, Canada

  2. 2

    Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

  3. 3

    University of Alberta, Department of Emergency Medicine, Edmonton, Alberta, Canada

*Kirk Magee, Department of Emergency Medicine, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax Infirmary, 1796 Summer Street, Halifax, Nova Scotia, B3H 3A7, Canada. kmagee@dal.ca. kmagee@hfx.eastlink.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions), comment added to review
  2. Published Online: 21 JAN 2009

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >